Your browser doesn't support javascript.
loading
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity.
Gutjahr, Julia C; Bayer, Elisabeth; Yu, Xiaobing; Laufer, Julia M; Höpner, Jan P; Tesanovic, Suzana; Härzschel, Andrea; Auer, Georg; Rieß, Tanja; Salmhofer, Astrid; Szenes, Eva; Haslauer, Theresa; Durand-Onayli, Valerie; Ramspacher, Andrea; Pennisi, Sandra P; Artinger, Marc; Zaborsky, Nadja; Chigaev, Alexandre; Aberger, Fritz; Neureiter, Daniel; Pleyer, Lisa; Legler, Daniel F; Orian-Rousseau, Veronique; Greil, Richard; Hartmann, Tanja N.
Afiliação
  • Gutjahr JC; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Bayer E; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Yu X; Karlsruhe Institute of Technology, Institute of Toxicology and Genetics.
  • Laufer JM; Biotechnology Institute Thurgau (BITg) at the University of Konstanz.
  • Höpner JP; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Tesanovic S; Department Biosciences, Paris-Lodron University of Salzburg.
  • Härzschel A; Department of Internal Medicine I, Medical Center and Faculty of Medicine, University of Freiburg.
  • Auer G; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Rieß T; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Salmhofer A; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Szenes E; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Haslauer T; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Durand-Onayli V; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Ramspacher A; Department Biosciences, Paris-Lodron University of Salzburg.
  • Pennisi SP; Department of Internal Medicine I, Medical Center and Faculty of Medicine, University of Freiburg.
  • Artinger M; Biotechnology Institute Thurgau (BITg) at the University of Konstanz, Kreuzlingen, Switzerland.
  • Zaborsky N; 1Laboratory for Immunological and Molecular Cancer Research.
  • Chigaev A; Department of Pathology and Cancer Center, University of New Mexico.
  • Aberger F; Department Biosciences, Paris-Lodron University of Salzburg.
  • Neureiter D; Institute of Pathology, Paracelsus Medical University Salzburg.
  • Pleyer L; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Legler DF; Biotechnology Institute Thurgau (BITg) at the University of Konstanz.
  • Orian-Rousseau V; Karlsruhe Institute of Technology, Institute of Toxicology and Genetics.
  • Greil R; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
  • Hartmann TN; 3rd Medical Department, SCRI-LIMCR, Paracelsus Medical University, Cancer Cluster Salzburg.
Haematologica ; 106(8): 2102-2113, 2021 08 01.
Article em En | MEDLINE | ID: mdl-32616529
ABSTRACT
Adhesive properties of leukemia cells shape the degree of organ infiltration and the extent of leukocytosis. CD44 and the integrin VLA-4, a CD49d/CD29 heterodimer, are important factors of progenitor cell adhesion in bone marrow (BM). Here, we report their cooperation in acute myeloid leukemia (AML) by a novel non-classical CD44-mediated way of inside-out VLA-4 activation. In primary AML BM samples from patients and the OCI-AML3 cell line, CD44 engagement by hyaluronan induced inside-out activation of VLA-4 resulting in enhanced leukemia cell adhesion on VCAM-1. This was independent from VLA-4 affinity regulation but based on ligand-induced integrin clustering on the cell surface. CD44-induced VLA-4 activation could be inhibited by the Src family kinase inhibitor PP2 and the multikinase inhibitor midostaurin. In further consequence, the increased adhesion on VCAM-1 allowed AML cells to strongly bind stromal cells. Thereby VLA-4/VCAM-1 interaction promoted activation of Akt, MAPK, NF-kB and mTOR signaling and decreased AML cell apoptosis. Collectively, our investigations provide a mechanistic description of an unusual CD44 function in regulating VLA-4 avidity in AML, supporting AML cell retention in the supportive BM microenvironment.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Integrina alfa4beta1 Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Integrina alfa4beta1 Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article